AVAH — Aveanna Healthcare Holdings Inc. stock price, charts and financials
QT87Aveanna Healthcare Holdings Inc.Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 7.74 | EPS (ttm) | 1.21 | Insider Own | 49.56% | Shs Outstand | 217.76M | Perf Week | -5.36% |
| Market Cap | 2.04B | Forward P/E | 12.06 | EPS next Y | 0.78 | Insider Trans | -29.69% | Shs Float | 47.09M | Perf Month | -1.78% |
| Enterprise Value | 3.34B | PEG | 0.69 | EPS next Q | - | Inst Own | - | Short Float | 2.07% | Perf Quarter | 41.18% |
| Income | 262.00M | P/S | 0.81 | EPS this Y | -41.55% | Inst Trans | - | Short Ratio | 2.38 | Perf Half Y | 12.36% |
| Sales | 2.52B | P/B | 8.49 | EPS next Y | 9.77% | ROA | 12.93% | Short Interest | 4.52M | Perf YTD | 14.57% |
| Book/sh | 1.10 | P/C | 10.78 | EPS next 5Y | 11.16% | ROE | 241.47% | 52W High | 10.32 -9.30% | Perf Year | 150.27% |
| Cash/sh | 0.87 | P/FCF | 14.97 | EPS past 3/5Y | - | ROIC | 15.86% | 52W Low | 3.74 150.27% | Perf 3Y | 441.04% |
| Dividend Est. | - | EV/EBITDA | 11.12 | Sales past 3/5Y | 10.81% 10.23% | Gross Margin | 32.67% | Volatility | 3.02% 3.92% | Perf 5Y | -7.60% |
| Dividend TTM | - | EV/Sales | 1.32 | EPS Y/Y TTM | 2234.04% | Oper. Margin | 11.48% | ATR (14) | 0.38 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.47 | Sales Y/Y TTM | 24.54% | Profit Margin | 10.37% | RSI (14) | 52.29 | Recom | 2.50 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.47 | EPS Q/Q | 80.00% | SMA20 | -2.53% | Beta | 1.91 | Target Price | 10.50 |
| Payout | 0.00% | Debt/Eq | 7.72 | Sales Q/Q | 15.92% | SMA50 | 10.81% | Rel Volume | 0.88 | Prev Close | 9.61 |
| Employees | 35,500 | LT Debt/Eq | 6.77 | Earnings | Aug 13 | SMA200 | 15.69% | Avg Volume | 2.07M | Price | 9.36 |
| IPO Date | Apr 28, 2021 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 43.83% 5.66% | Net Debt/EBITDA | 4.39 | Volume | 1,814,304 | Change | -2.60% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-14-26 | Reiterated | Truist Securities | Hold | $9.00 → $11 |
| Jun-03-26 | Upgrade | RBC Capital | Sector Perform → Outperform | |
| May-20-26 | Reiterated | Truist Securities | Hold | $10 → $9.00 |
| May-18-26 | Reiterated | Barclays | Overweight | $11 → $9.00 |
| May-15-26 | Upgrade | Stephens & Co. | Equal Weight → Overweight | $11 |
| Mar-12-26 | Reiterated | Truist Financial | Hold | $9.50 → $10 |
| Jan-16-26 | Reiterated | Barclays | Overweight | $5.00 → $11 |
| Jan-15-26 | Reiterated | UBS | Neutral | $9.00 → $10 |
| Jan-15-26 | Reiterated | RBC Capital | Sector Perform | $10 → $11 |
| Dec-05-25 | Reiterated | Raymond James | Outperform | $9.00 → $13 |
Aveanna Healthcare Holdings Inc. operates as a diverse platform for home-based care services throughout the United States. The company delivers a range of critical offerings, including private duty nursing (PDN), adult home health and hospice care, in-home pediatric therapy, and enteral nutrition services. Its patient-centered approach allows individuals to receive essential medical care within their own homes, effectively reducing the need for costly institutional settings such as hospitals. The company's operations are structured into three key segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment provides specialized private duty nursing, which includes skilled nursing care for medically fragile children at home, nursing support in school environments, and services at pediatric day healthcare centers. This segment also offers employer-of-record support, personal care services, and pediatric therapy (physical, occupational, and speech) provided both in clinics and patients' residences. The HHH segment focuses on home health services, encompassing in-home skilled nursing, physical, occupational, and speech therapy, as well as medical social work and aide assistance. Furthermore, it delivers hospice services, offering compassionate care to patients and their families when life-limiting illnesses no longer respond to curative treatments. The MS segment supplies enteral nutrition products and other vital medical supplies to adults and children, distributed on either a scheduled or as-needed basis. Founded in 2016, Aveanna Healthcare Holdings Inc. is headquartered in Atlanta, Georgia.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 1/3/2026 | FY 2024 12/28/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,522 | 2,433 | 2,025 | 1,895 | 1,788 | 1,679 | 1,495 | 1,384 | 1,254 | |
| Cost of Goods Sold Incl. D&A | 1,699 | 1,628 | 1,389 | 1,300 | 1,234 | 1,136 | 1,041 | 965 | 859 | |
| Gross Profit | 824 | 805 | 636 | 595 | 553 | 542 | 455 | 419 | 394 | |
| Selling, General and Administrative Excl. Other | 525 | 527 | 470 | 465 | 484 | 420 | 355 | 341 | 322 | |
| Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other Operating Expense | 9 | 13 | 26 | 122 | 712 | 159 | 103 | 39 | 18 | |
| Operating Income | 289 | 265 | 140 | 8 | -642 | -36 | -3 | 39 | 39 | |
| Interest Expense | 133 | 140 | 157 | 153 | 108 | 69 | 83 | 92 | 76 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | -15 | -18 | 22 | 6 | 86 | -9 | 35 | -22 | -13 | |
| Net Income Before Taxes | 141 | 107 | 5 | -139 | -664 | -114 | -52 | -75 | -50 | |
| Income Taxes | -121 | -118 | 16 | -4 | -2 | 3 | 5 | 1 | -3 | |
| Consolidated Net Income | 262 | 225 | -11 | -135 | -662 | -117 | -57 | -77 | -47 | |
| Net Income From Continuing Operations | 262 | 225 | -11 | -135 | -662 | -117 | -57 | -77 | -47 | |
| Net Income | 262 | 225 | -11 | -135 | -662 | -117 | -57 | -77 | -47 | |
| EPS (Recurring) | 1.27 | 1.10 | -0.06 | -0.71 | -3.57 | -0.63 | -0.31 | -0.41 | -0.26 | |
| EPS (Basic, Before Extraordinaries) | 1.27 | 1.10 | -0.06 | -0.71 | -3.57 | -0.63 | -0.31 | -0.41 | -0.26 | |
| EPS (Diluted) | 1.21 | 1.05 | -0.06 | -0.71 | -3.57 | -0.63 | -0.31 | -0.41 | -0.26 | |
| EBITDA | 300 | 275 | 187 | 39 | -525 | -18 | 61 | 44 | 96 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 7.74 | 7.70 | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.80 | 0.68 | 0.44 | 0.27 | 0.08 | 0.82 | — | — | — | |
| Gross Margin | 32.67 | 33.09 | 31.41 | 31.40 | 30.93 | 32.28 | 30.43 | 30.27 | 31.42 | |
| Operating Margin | 11.46 | 10.89 | 6.91 | 0.42 | -35.91 | -2.14 | -0.20 | 2.82 | 3.11 | |
| Net Margin | 10.39 | 9.25 | -0.54 | -7.12 | -37.02 | -6.97 | -3.81 | -5.56 | -3.75 | |
| Shares Outstanding | 215 | 204 | 193 | 190 | 186 | 185 | 186 | 186 | 180 | |
| Market Capitalization | 2,012 | 1,648 | 899 | 509 | 145 | 1,369 | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| WILLIAMS ROBERT M JR | 10% Owner | Jun 30 '26 | Sale | 8.01 | 3,000,000 | 24,029,999 | 190,130 | Jul 02 |
| VIGANO PAUL R | 10% Owner | Jun 30 '26 | Sale | 8.01 | 3,000,000 | 24,029,999 | 190,130 | Jul 02 |
| J.H. Whitney Equity Partners VII, LLC | 10% Owner | Jun 30 '26 | Sale | 8.01 | 2,419,035 | 19,376,470 | 10,112,123 | Jul 02 |
| WILLIAMS ROBERT M JR | 10% Owner | Jun 24 '26 | Sale | 8.00 | 1,000,000 | 8,000,000 | 245,251 | Jun 26 |
| J.H. Whitney Equity Partners VII, LLC | 10% Owner | Jun 24 '26 | Sale | 8.00 | 919,389 | 7,355,112 | 12,531,158 | Jun 26 |
| VIGANO PAUL R | 10% Owner | Jun 24 '26 | Sale | 8.00 | 1,000,000 | 8,000,000 | 245,251 | Jun 26 |
| WILLIAMS ROBERT M JR | 10% Owner | Jun 03 '26 | Sale | 6.24 | 7,000,000 | 43,680,000 | 252,899 | Jun 05 |
| VIGANO PAUL R | 10% Owner | Jun 03 '26 | Sale | 6.24 | 7,000,000 | 43,680,000 | 252,899 | Jun 05 |
| J.H. Whitney Equity Partners VII, LLC | 10% Owner | Jun 03 '26 | Sale | 6.24 | 5,842,240 | 36,455,578 | 13,450,547 | Jun 05 |
| Cunningham Patrick A. | Chief Compliance Officer | May 20 '26 | Sale | 7.59 | 125,000 | 948,538 | 212,755 | May 21 |
| Cunningham Patrick A. | Chief Compliance Officer | Feb 19 '26 | Sale | 7.21 | 18,436 | 132,890 | 337,755 | Feb 19 |
| Buckhalter Matthew | Chief Financial Officer | Feb 19 '26 | Sale | 7.21 | 13,512 | 97,397 | 529,243 | Feb 19 |
| Shaner Jeff | Chief Executive Officer | Feb 19 '26 | Sale | 7.21 | 173,225 | 1,248,640 | 2,650,892 | Feb 19 |
| Stewart Deborah | SVP, Chief Accounting Officer | Feb 19 '26 | Sale | 7.21 | 11,181 | 80,595 | 301,807 | Feb 19 |
| Reisz Edwin C. | Chief Administrative Officer | Feb 19 '26 | Sale | 7.21 | 60,769 | 438,035 | 1,447,057 | Feb 19 |